Clinical Trial Update: A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Zavegepant for acute treatment of migraine in children; recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Zavegepant (zavegepant)

Snippet

Sponsor: Pfizer | Conditions: Acute Treatment of Migraine | Phase 1 | Status: RECRUITING